Scarica l'app Stockscreener
1.90
0.52%
-0.01
Pre-mercato:
1.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DRRX Giù?
Forum
Previsione
Frazionamento azionario
Durect Corp Borsa (DRRX) Ultime notizie
DURECT Corporation Reversal Rally May Surprise BearsQuarterly Market Summary & Short-Term Trading Opportunity Alerts - 선데이타임즈
Will DURECT Corporation continue its uptrendQuarterly Market Review & Verified Entry Point Signals - Newser
Sentiment analysis tools applied to DURECT Corporation2025 Volatility Report & Growth-Oriented Investment Plans - Newser
Durect: Q2 Earnings Snapshot - Connecticut Post
Can swing trading help recover from DURECT Corporation losses [Portfolio Profit Report]Weekly Top Gainers Trade List - Newser
Published on: 2025-08-12 20:28:09 - Newser
Using economic indicators to assess DURECT Corporation potentialJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
DURECT (DRRX) Reports Q2 2025 Results, Press Release Attached | DRRX SEC FilingForm 8-K - Stock Titan
Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan
Market reaction to DURECT Corporation’s recent newsMomentum-Based Prediction for Quick Returns - Newser
Why DURECT Corporation stock attracts strong analyst attentionPredictive Analytics for Equity Growth Potential - Newser
Technical signs of recovery in DURECT CorporationTechnical Insight Guide for Safer Trades - Newser
How is DRRX performing? - AInvest
Is DURECT Corporation reversing from oversold territoryFree Daily Top Performing Stock Insights - Newser
Using data tools to time your DURECT Corporation exitEquity Performance Forecast Based on AI Models - Newser
Reversal indicators forming on DURECT Corporation stockPortfolio Update Report & Expert Curated Trade Ideas - Newser
DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World
Signal strength of DURECT Corporation stock in tech scannersReal-Time Entry Forecast with Accuracy Metrics - Newser
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey
Durect Extends Tender Offer Deadline in Merger with Bausch Health. - AInvest
Using R and stats models for DURECT Corporation forecastingAlpha Generation Strategy with Low Volatility - Newser
Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser
What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News
Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress
What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser
Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser
Bausch Health files SC TO-C ahead of tender offer for DURECT (DRRX) | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health expands liver disease portfolio with DURECT Corp buy - The Pharma Letter
Can swing trading help recover from DURECT Corporation lossesSwing Watchlist With Tight Stop Placement - Newser
What does recent volatility data suggest for DURECT CorporationLow Risk High Confidence Watchlist Builder - Newser
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Durect Corp: Analyzing DRRX Stock Trends - investchronicle.com
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside - FinancialContent
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - inkl
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views - Benzinga
Bausch Health to buy Durect for $63M upfront; Fulcrum’s Ph1b sickle cell data - Endpoints News
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings - Benzinga
Bausch Health stock rises, Durect flies after acquisition deal By Investing.com - Investing.com Canada
Bausch Health stock rises, Durect flies after acquisition deal - Investing.com
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders - Business Wire
Durect stock rises on M&A deal with Bausch Health (BHC:NYSE) - Seeking Alpha
DRRX to be acquired by Bausch for $1.75 cash + CVR worth up to $350M | DRRX SEC FilingForm 8-K - Stock Titan
Bausch Health To Acquire DURECT; Expanding Liver Disease Pipeline With Larsucosterol - Nasdaq
Bausch Health to acquire DURECT in $63 million deal for liver disease drug - Investing.com Canada
Bausch Health to acquire DURECT for $63 million upfront By Investing.com - Investing.com Canada
Bausch Health to launch tender offer for DURECT; Schedule TO-C filed | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - PR Newswire
When is the best time to exit AA Mission Acquisition Corp.Free Community Shared Smart Money Signals - Newser
Is ICF International Inc. stock overhyped or has real potentialFree Low Risk Buy Zone Opportunity Watch - Newser
How Aeries Technology Inc Equity Warrant stock performs during market volatilityFree Accurate Technical Trend Reversal Picks - Newser
Short Term Trend Reversal in DURECT Corporation PossibleLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
How to forecast Kornit Digital Ltd. trends using time seriesBreakout Monitoring with Momentum Analysis - Newser
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):